← Leaderboards
William Donald Shields
University Of California Los Angeles
$2,905,530
Attributed
$2,905,530
Total exposure
7
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$2,905,530 · 7
By mechanism
M01$2,905,530 · 7
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Jerome None Engel$22,981,738
- Rochelle Caplan$3,789,363
- Jeffrey L. Cummings$25,787,245
- Carolyn R Houser$10,997,801
- Istvan Mody$21,296,369
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman Therapy EvaluationHuman SubjectDrug Screening /EvaluationAnticonvulsantsPediatric PharmacologyChild (0-11)EpilepsyBrain Disorder ChemotherapyAcetamidesInfant Human (0-1 Year)PharmacokineticsSpasmNervous System Disorder ChemotherapyPlacebosHemiplegiaClinical TrialsNeurosurgeryPartial SeizureOutcomes ResearchPediatricsCerebral CortexMiddle Childhood (6-11)Convulsions
Grant awards (16)
UCBL059 IN CHILDREN W/ EPILEPSY$207,266
M01 · FY2001 · RR
UCB L059 IN CHILDREN W/ PARTIAL ONSET SEIZURES$207,266
M01 · FY2001 · RR
OPEN LABEL STUDY OF TOPOMAX IN SUBJECTS W/ INFANTILE SPASMS$207,266
M01 · FY2001 · RR
OPEN LABEL STUDY OF TOPOMAX IN SUBJECTS W/ INFANTILE SPASMS$207,266
M01 · FY2001 · RR
UCBL059 IN CHILDREN W/ EPILEPSY$207,266
M01 · FY2001 · RR
STUDY OF TOPIMAX TOPIRAMATE IN CHILDREN WITH LENNOX-GASTAUT SYNDROME$207,266
M01 · FY2001 · RR
STUDY OF TOPIMAX TOPIRAMATE IN CHILDREN WITH LENNOX-GASTAUT SYNDROME$207,266
M01 · FY2001 · RR
STUDY OF TOPIRAMATE IN SUBJECTS WITH LENNOX-GASTAUT SYNDROME$207,266
M01 · FY2001 · RR
STUDY OF TOPIRAMATE IN SUBJECTS WITH LENNOX-GASTAUT SYNDROME$207,266
M01 · FY2001 · RR
OUTCOME OF SURGERY FOR INFANTILE SPASMS$207,266
M01 · FY2001 · RR
MULTI CENTER, RANDOMIZED, DOUBLE BLIND STUDY OF OXCABAZEPINE ADJUNCTIVE THERAPY$207,266
M01 · FY2001 · RR
MULTI CENTER, RANDOMIZED, DOUBLE BLIND STUDY OF OXCABAZEPINE ADJUNCTIVE THERAPY$207,266
M01 · FY2001 · RR
OUTCOME OF SURGERY FOR INFANTILE SPASMS$207,266
M01 · FY2000 · RR
UCB L059 IN CHILDREN W/ PARTIAL ONSET SEIZURES$207,266
M01 · FY2000 · RR
UCB L059 IN CHILDREN W/ PARTIAL ONSET SEIZURES$1,903
M01 · FY2000 · RR
OUTCOME OF SURGERY FOR INFANTILE SPASMS$1,903
M01 · FY2000 · RR